ESBLt
ESBLt is not a widely recognized term in peer‑reviewed microbiology or clinical pharmacology. In most scientific and clinical contexts, the abbreviation ESBL refers to extended‑spectrum beta‑lactamases, enzymes produced by certain bacteria that confer resistance to many beta‑lactam antibiotics. If encountered, ESBLt may be a typographical variant or an informal/context‑specific label rather than a standard designation. This article describes ESBLs in general and notes the uncertainty around the term ESBLt.
Extended‑spectrum beta‑lactamases are enzymes that hydrolyze a broad range of beta‑lactam antibiotics, including penicillins and cephalosporins,
Epidemiology and impact: ESBL‑producing organisms are encountered in both hospital and community settings and are associated
Treatment and control: Carbapenems have been a mainstay for serious ESBL infections, though stewardship and newer